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Meningococcal Vaccines: Methods and Protocols. Eds.
A. J. Pollard and M. C. J. Maiden. Humana Press,
2001. Pp. 416. $120.00.
The meningococcus, causing meningitis and septicaemia, is
a leading infectious cause of childhood death in indus-
trialized countries and results in major epidemics in the
countries of the ‘Meningitis Belt’ of sub-Saharan Africa.
Meningococcal outbreaks in Northern Europe, some areas
of the United States and more recently New Zealand have
heightened the sense of alarm expressed by both the public,
the press and the healthcare professions. This undercurrent
has resulted in considerable pressure on national immuniza-
tion agencies to implement a meningococcal vaccine
programme.
The development of polysaccharide-conjugate vaccines
for some serogroups such as C, A, Y and W-135 is likely to
have a dramatic impact on the incidence of the disease.
Nonetheless, these vaccines may require further modifica-
tion, we will need the necessary tools to monitor the long-
term immunological response to these vaccines, and it will
be necessary to conduct surveillance to ensure that sero-
group replacement by a non-vaccine strain does not take
place. A vaccine that provides widespread protection against
the serogroup B meningococcus remains remarkably elusive.
With the completion of several of the meningococcal
genome sequencing projects, many new candidate serogroup
B vaccines will require pre-clinical and clinical testing, and
again we will need the necessary tools to assess them.
Although the burden of meningitis and septicaemia in the
world has attracted considerable research effort in defining
the epidemiology, cellular and molecular pathogenesis and
vaccinology of these diseases, to date there has been no text
where the technical aspects have been addressed. In
Meningococcal Vaccines, the first of two companion vol-
umes, Andrew Pollard and Martin Maiden have gathered
together an outstanding group of clinical and laboratory
scientists to provide a comprehensive set of protocols for the
development and evaluation of meningococcal vaccines. In
28 chapters, the book covers everything from the immune
response to vaccine implementation, and from capsular
polysaccharide or outer membrane vesicle purification to T-
cell epitope mapping.
The strength of this text is that it provides a key reference
source, enabling researchers in the field to avoid re-inventing
the wheel. The text also provides the basis for the
development of new ideas. Each chapter takes a step-by-step
approach with clearly set out notes highlighting the problem
areas. All the chapters have comprehensive bibliographies,
and are well structured. The text is easily accessible and is
recommended to those who are seeking to critically appraise
the field of meningococcal vaccines.
r. s. heyderman
Department of Pathology and Microbiology,
Uniersity of Bristol
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ABC of AIDS, 5th edn. Ed. M. W. Adler. BMJ 2001.
Pp. 118.
This is the fifth edition of this popular book, based on a
series of the same name originally published almost 15 years
ago in the British Medical Journal. It is aimed at non-
specialist doctors and medical students working in the UK,
and provides a clear, readable and authoritative account of
the clinical aspects of HIV disease and their management. It
is well illustrated and attractively produced, making good
use of boxes in which key points can be identified at a
glance. It does not fit in the pocket, being of A4 size, but is
concise (110 pages), and as up to date as a textbook can be
in this fast-moving field. It covers the epidemiology, virology
and immunology of HIV infection, and contains chapters
on prevention and counselling; but it is primarily a clinical
book, with chapters on HIV related tumours, HIV and the
lung, gut and nervous system; natural history and treat-
ment; and HIV in children, injecting drug users and the
developing world. The chapters are all written by well
respected authorities in their fields, mostly in the United
Kingdom. This new edition is the first since 1997, and will
no doubt ensure that the ABC of AIDS remains as popular
and useful as ever.
david mabem
London School of Hygiene and Tropical Medicine
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Public Health Systems and the Emerging Infections –
Assessing the Capabilities of the Public and Priate
Sectors. Eds. J. R. Davis and X. Lederberg. National
Academy Press 2001. £16.45.
This volume gives a timely and disturbing account of front
line public health facilities in the USA. It reports on the
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discussions of the fourth workshop of the Forum on
Emerging Infections that was founded in 1996 in response
to a request from the Centers for Disease Control and
Prevention (CDC) and the National Institutes of Health.
The Forum attempts to provide and exchange information
and to bring neglected issues to the attention of policy
makers. The themes raised have a resonance in other
systems and reinforce some of our fears about possible
weaknesses that may result from current trends and struc-
tural developments in the health sector. With the exception
of the inclusion of Canada (in the context of Toronto’s
participation in FoodNet), however, this is a totally paro-
chial account of public health in the USA and there are no
comparisons with other countries many of which would have
provided good exemplars ; maybe this will be remedied by
the fifth workshop on international aspects.
The first theme concentrates upon the ways in which
traditional public health concerns with infectious disease
and its control was supplanted in developed countries with
concerns about chronic illnesses and preventive measures
that involve life style modifications. At the same time the
population expected a high quality of personal health care.
Delivery of health care through managed care developments
such as health maintenance organisations (HMO’s) became
the preoccupation of health policy analysts who seemed not
to take on board the erosion of public health facilities and
the increasingly complex health care structures that needed
to be coordinated if adequate surveillance systems were to
be maintained. The public health laboratory service in the
USA has faced reorganisation and privatisation. The high-
volume low-cost tests have increasingly become the task of
the private sector whilst more complex, costly tests remain
with the public sector. At the same time the impression, not
born out by surveys of managed care institutions, was that
competitive pressures on health services was leading to
fewer tests and more empiric treatment of disease and in
consequence less accurate and complete infectious disease
reporting.
The second theme draws attention to the significant gaps
in the information collected about infectious disease and
disjunctions of flows of information between states and
within states and between private and public sectors. The
State rather than the Federal authorities have responsibility
for public health and monitoring infectious disease. As a
result incompatible information systems have evolved. The
timely collection and transmission of comparable infor-
mation between and to states, federal agencies and other
relevant groups is desperately needed. This involves com-
mitment and resources in educating clinicians, developing
medical and laboratory record systems and training staff.
In spite of the development of sentinel practices and
the introduction of FoodNet, at the instigation of CDC,
the public health infrastructure is patchy and communi-
cations poor. The ‘ laboratory reporting in most state health
departments is still surface mail, with a measured 10–14 day
time lag in some states ’ (page 23). The introduction of
electronic communication systems is recommended.
The need for resources and trained staff in local public
health agencies is another theme highlighted. A nurse, a
sanitarian, a clerk, and a part-time health officer often staff
these small local agencies. These workers appear to be
relatively untrained as they are said to need ‘basic investi-
gative skills, questionnaire design, interviewing techniques
and collection of environmental and clinical specimens’
(page 36). In addition the importance of computerization is
stressed to ensure that ‘Electronic communication systems
need to be strengthened so that outbreaks can be shared and
resources for use during the outbreak can be obtained’
(page 36). Such basic inadequacies give cause for concern.
The writers recognize that public health surveillance
systems need development and funds. This of course requires
more attention to raising the profile of public health at
Federal and State level. The State and Federal agencies are
deemed to place a high value on public health activities but
there is inevitable competition for scarce resources and these
activities do not have a high profile. The hidden nature of
many public health activities and its apparent success in
controlling high profile outbreaks give the false impression
that all is well. Ways of bringing the importance of public
health to the attention of the public are examined including
their role in emerging diseases and bioterrorism.
Unfortunately the profile and the improved functioning
of the system have not proceeded at the pace that was
probably needed to deal with the events that are currently
unfolding, such as the anthrax attacks.
There are undoubted jewels in the public health system in
the USA, such as the CDC, but these resources are not likely
to be sufficient to deal with complex issues that may arise
throughout the country. There is a need for well informed
practitioners, comprehensive surveillance systems and rapid
communication systems. The present fragmentation of
services, duplication and incompatible systems of data
collection has to be tackled. Other healthcare systems, such
as those in the UK, currently going down the path of
developing Primary Health Care Trusts (not dissimilar to
the HMO’s in the USA), need to be vigilant lest they
also lead to the dislocation of traditional public health
information systems and networks.
This is a lively piece of work although it would have
benefited from a focused conclusion that brought together
evidence from the various sessions and proposals for future
developments. It would be easier to read if there were fewer
split infinitives. Nevertheless it provides salutary reading for
anyone interested in the ability of public health services
to protect the public from infections and environmental
hazards.
jenny roberts
SHTM, London School of Hygiene and Tropical Medicine
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New Challenges to Health: The Threat of Virus Infec-
tion. Eds. G. L. Smith, W. L. Irving, J. W. Mc Cauley
and D. J. Rowlands. Cambridge University Press,
2001. Pp. 347. £70. ISBN 0 521 80614 3.
Epidemics of infectious disease can have extreme socio-
economic impact and we are living through an age when
emerging disease is very much in the public eye. It is fitting
then that this book should have been produced from the
proceedings of a meeting that focused on the impact on
health of emerging viral diseases. It includes a discussion of
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a number of important virus systems and, unusually, reviews
both the molecular biology and epidemiology of a number
of selected systems. The chapters, each written by an expert
in the field, include: surveillance of emerging viruses ;
epidemiology of microparasites ; bunyaviruses and hanta-
viruses ; the impact and spread of calcivirus and myxoma
virus in Australia ; influenza A viruses ; hepatitis viruses ;
HIV and AIDS; morbilliviruses ; prion protein; xenotrans-
plantation and endogenous viruses ; herpesviruses and
neoplasia ; the proteins of Marburg and Ebola viruses ;
Dengue virus epidemiology; Borna disease virus and
antiviral drug development.
This book is an excellent reference for students and
researchers alike and scores well on topicality, authoritative-
ness and accuracy. In addition it is presented in an easily
accessible format that should encourage student attention.
p. roy
London School of Hygiene & Tropical Medicine
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Essentials of Antimicrobial Pharmacology. Ed. P. H.
Axelsen. Humana Press, 2001. Pp. 141. $24.50 pb.
ISBN 0 896 03842 4.
This book is intended as a guide to antibiotics rather than a
textbook, a pocket volume for reference or an adjunct to
lectures. Certainly most of the topics that could fall under
the title of antimicrobial chemotherapy are packed into the
121 pages of text. A background chapter on sensitivity
testing, pharmacokinetics and resistance precedes more
substantial chapters on antibacterials, antifungals, anti-
parasitics and antivirals (in that order). It ends with a short
chapter on immunomodulators and vaccines. The aims are
laudable, a succinct text that also includes lists of all drugs
used including the generic and trade names, must be useful.
The classes of compounds considered are comprehensive
and includes the recently marketed oxazolidinones, the first
novel class of antibacterials to appear for decades. It
includes short sections on investigational drugs and,
although without references, is up to date.
So it is a pity that the volume has editorial and factual
errors large enough to make one re-examine every section
and prevent any recommendation. There are too many
errors to list – but they range from mis-spelling (Shistosoma,
artemisinine), to loss of format (anthelmintic agents, p. 83)
and inadequate explanation of mechanisms of action
[amphotericin B binds to ergosterol in the cell membrane
not the cell wall (p. 65), antifolate drugs inhibit pyrimidine
synthesis and not purine synthesis (pp. 28–29)]. Attention to
detail and replacement of the inadequate 12 pages on
immunisation by more on the antimicrobials and drug
resistance would greatly improve this volume.
s. croft
London School of Hygiene & Tropical Medicine
